AR096851A1 - Sales que no forman hidratos ni solvatos de nalmefeno - Google Patents
Sales que no forman hidratos ni solvatos de nalmefenoInfo
- Publication number
- AR096851A1 AR096851A1 ARP140102531A ARP140102531A AR096851A1 AR 096851 A1 AR096851 A1 AR 096851A1 AR P140102531 A ARP140102531 A AR P140102531A AR P140102531 A ARP140102531 A AR P140102531A AR 096851 A1 AR096851 A1 AR 096851A1
- Authority
- AR
- Argentina
- Prior art keywords
- salt
- salts
- hydrogen
- refers
- nalmefeno
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
- C07D489/08—Oxygen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epidemiology (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Emergency Medicine (AREA)
Abstract
La presente se refiere a sales de nalmefeno las cuales pertenecen a al menos a una de las dos categorías siguientes: sales que no forman hidratos y sales que no forman solvatos. En particular, la presente se refiere a la sal hidrogenoadipato, la sal hidrogenomalonato, la sal lactato, la sal hidrogenofumarato, la sal hidrogenosuccinato, la sal bencenosulfonato, la sal hidrogenomaleato y la sal salicilato de nalmefeno. La presente también se refiere a tales sales para su uso en terapia. Reivindicación 1: Una sal del compuesto de fórmula (1) donde dicha sal pertenece a al menos una de las dos categorías siguientes: a) sal que no forma hidratos; b) sal que no forma solvatos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA201300421 | 2013-07-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR096851A1 true AR096851A1 (es) | 2016-02-03 |
Family
ID=51177066
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP140102531A AR096851A1 (es) | 2013-07-11 | 2014-07-08 | Sales que no forman hidratos ni solvatos de nalmefeno |
Country Status (27)
Country | Link |
---|---|
US (2) | US9725458B2 (es) |
EP (1) | EP3019500B1 (es) |
JP (1) | JP6491653B2 (es) |
KR (1) | KR20160030130A (es) |
CN (1) | CN105377854B (es) |
AR (1) | AR096851A1 (es) |
AU (1) | AU2014289182B2 (es) |
CA (1) | CA2917576C (es) |
CL (1) | CL2015003736A1 (es) |
CY (1) | CY1122099T1 (es) |
DK (1) | DK3019500T3 (es) |
EA (1) | EA031747B1 (es) |
ES (1) | ES2749614T3 (es) |
HR (1) | HRP20191764T1 (es) |
HU (1) | HUE046904T2 (es) |
IL (1) | IL243243B (es) |
LT (1) | LT3019500T (es) |
ME (1) | ME03504B (es) |
MX (1) | MX2016000006A (es) |
PH (1) | PH12016500052B1 (es) |
PL (1) | PL3019500T3 (es) |
PT (1) | PT3019500T (es) |
RS (1) | RS59349B1 (es) |
SG (1) | SG11201600116VA (es) |
SI (1) | SI3019500T1 (es) |
TW (1) | TW201536288A (es) |
WO (1) | WO2015004240A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR096851A1 (es) | 2013-07-11 | 2016-02-03 | H Lundbeck As | Sales que no forman hidratos ni solvatos de nalmefeno |
US20220280494A1 (en) * | 2019-08-28 | 2022-09-08 | Delpor, Inc. | Compositions for small molecule therapeutic agent compounds |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU196376B (en) * | 1985-05-23 | 1988-11-28 | Sandoz Ag | Process for preparing morphinane derivatives and pharmaceutical compositions containing such compounds |
US20030153590A1 (en) | 2001-08-14 | 2003-08-14 | Oy Contral Pharma Ltd | Method of treating alcoholism or alcohol abuse |
CN102036993B (zh) * | 2008-04-24 | 2014-06-25 | 詹森药业有限公司 | 纳美芬二酯前药 |
GB0814043D0 (en) * | 2008-07-31 | 2008-09-10 | Serentis Ltd | The treatment of skin disorders |
UA102128C2 (en) * | 2008-12-05 | 2013-06-10 | Х. Луннбек А/С | Nalmefene hydrochloride dihydrate |
DK2435439T3 (en) * | 2009-05-25 | 2016-02-29 | Lundbeck & Co As H | PREPARATION OF nalmefene HYDROCHLORIDE FROM naltrexone |
LT2635586T (lt) | 2010-11-05 | 2017-04-10 | H. Lundbeck A/S | Naltreksono gamybos būdas |
CN103012416B (zh) | 2011-09-28 | 2015-07-01 | 辽宁海思科制药有限公司 | 一种盐酸纳美芬的制备方法 |
AR096851A1 (es) | 2013-07-11 | 2016-02-03 | H Lundbeck As | Sales que no forman hidratos ni solvatos de nalmefeno |
-
2014
- 2014-07-08 AR ARP140102531A patent/AR096851A1/es unknown
- 2014-07-10 EP EP14738819.3A patent/EP3019500B1/en active Active
- 2014-07-10 ME MEP-2019-252A patent/ME03504B/me unknown
- 2014-07-10 CA CA2917576A patent/CA2917576C/en active Active
- 2014-07-10 HU HUE14738819A patent/HUE046904T2/hu unknown
- 2014-07-10 DK DK14738819.3T patent/DK3019500T3/da active
- 2014-07-10 CN CN201480039127.2A patent/CN105377854B/zh not_active Expired - Fee Related
- 2014-07-10 EA EA201592228A patent/EA031747B1/ru not_active IP Right Cessation
- 2014-07-10 PT PT147388193T patent/PT3019500T/pt unknown
- 2014-07-10 LT LT14738819T patent/LT3019500T/lt unknown
- 2014-07-10 RS RSP20191242 patent/RS59349B1/sr unknown
- 2014-07-10 MX MX2016000006A patent/MX2016000006A/es unknown
- 2014-07-10 SG SG11201600116VA patent/SG11201600116VA/en unknown
- 2014-07-10 TW TW103123770A patent/TW201536288A/zh unknown
- 2014-07-10 ES ES14738819T patent/ES2749614T3/es active Active
- 2014-07-10 WO PCT/EP2014/064819 patent/WO2015004240A1/en active Application Filing
- 2014-07-10 PL PL14738819T patent/PL3019500T3/pl unknown
- 2014-07-10 AU AU2014289182A patent/AU2014289182B2/en not_active Ceased
- 2014-07-10 US US14/903,384 patent/US9725458B2/en active Active
- 2014-07-10 JP JP2016524824A patent/JP6491653B2/ja active Active
- 2014-07-10 SI SI201431368T patent/SI3019500T1/sl unknown
- 2014-07-10 KR KR1020157037096A patent/KR20160030130A/ko not_active Application Discontinuation
-
2015
- 2015-12-20 IL IL243243A patent/IL243243B/en active IP Right Grant
- 2015-12-28 CL CL2015003736A patent/CL2015003736A1/es unknown
-
2016
- 2016-01-07 PH PH12016500052A patent/PH12016500052B1/en unknown
-
2017
- 2017-06-12 US US15/619,645 patent/US9938286B2/en active Active
-
2019
- 2019-09-27 HR HRP20191764TT patent/HRP20191764T1/hr unknown
- 2019-10-03 CY CY20191101030T patent/CY1122099T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CU20200004A7 (es) | Compuestos para tratar afecciones asociadas con la actividad nlrp | |
CY1122222T1 (el) | Συνθεση βορονικων αλατων και χρησεις αυτων | |
AR110381A2 (es) | Inhibidores biarilo de tirosina cinasa de bruton | |
BR112015021521A2 (pt) | anticorpos anti-crth2 e métodos para seu uso | |
BR112015029686A2 (pt) | composições para o tratamento de superfícies compreendendo corantes fotocrômicos | |
BR112015028870A2 (pt) | estruturas fibrosas hidroentrelaçadas | |
UY35683A (es) | Polimorfo de inhibidores de tirosina quinasa de bazo (syk) | |
CR20160099A (es) | Formulación de inhibidores de la syk | |
CR20150418A (es) | Compuestos de tetrahidropirrolotiazina | |
CY1118950T1 (el) | Νεα παραγωγα πυραζολιου | |
CL2016001458A1 (es) | Derivado de sulfonamida o sales de adición de ácido farmaceuticamente aceptables del mismo. | |
AR098274A1 (es) | Inhibidor de grelina o-acil transferasa | |
CR20150663A (es) | Derivados de diazacarbazol como ligandos de tau para pet | |
MX2016005760A (es) | Inhibidores de glucogeno sintasa cinasa 3 (gsk-3). | |
AR093335A1 (es) | Sales amina de laquinimod | |
TWD163870S (zh) | 盒 | |
BR112015013984A2 (pt) | métodos para o tratamento de prurido | |
AR095097A1 (es) | Compuestos de fenoxietoxi | |
MX366765B (es) | Agonistas de receptores gamma activados por el proliferador de peroxisoma para el tratamiento de esclerósis múltiple. | |
CL2016001546A1 (es) | Composición para el cuidado oral que comprende serina y al menos una sal de zinc. | |
TWD158438S (zh) | 影像顯示器 | |
AR095015A1 (es) | Compuestos de azetidiniloxifenilpirrolidina | |
CL2016000019A1 (es) | Compuestos derivados de dihidroxifenilo deuterado o una sal de los mismos; composición farmacéutica que los comprende y su uso para el tratamiento de trastornos mediados por neurotransmisores tales como hipotensión, trastornos del sueño, enfermedad de alzheimer y depresión. | |
CL2015001289A1 (es) | Nuevos derivados de 1,4-ditiina sustituida y su uso como fungicidas | |
AR096851A1 (es) | Sales que no forman hidratos ni solvatos de nalmefeno |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |